What Have We Learned About Transmission of Coronavirus Disease-2019 : Implications for Pulmonary Function Testing and Pulmonary Procedures - 19/04/23

Doi : 10.1016/j.ccm.2022.11.005

David A. Kaminsky, MD ^a,^⁎ , Shaikh M. Noor Husnain, MD ^b, Danai Khemasuwan, MD, MBA, FCCP, ATSF ^c
^a Pulmonary and Critical Care, University of Vermont Larner College of Medicine, Given D213, 89 Beaumont Avenue, Burlington, VT 05405, USA
^b Department of Pulmonary and Critical Care, Section of Interventional Pulmonary, Westchester Medical Center, 100 Woods Road, Valhalla, NY 10595, USA
^c Pulmonary and Critical Care, Virginia Commonwealth University Health System, 1200 East Broad Street, Richmond, VA 23298, USA

^∗Corresponding author.

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Because of the potential for high aerosol transmission during pulmonary function testing and pulmonary procedures, performing these tests and procedures must be considered carefully during the coronavirus disease-2019 (COVID-19) pandemic. Much has been learned about the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by aerosols and the potential for such transmission through pulmonary function tests and pulmonary procedures, and subsequently preventative practices have been enhanced and developed to reduce the risk of transmission of virus to patients and personnel. This article reviews what is known about the potential for transmission of SARS-CoV-2 during pulmonary function testing and pulmonary procedures and the recommended mitigation steps to prevent the spread of COVID-19.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, SARS-CoV-2, Aerosol transmission, Pulmonary function testing, Bronchoscopy, Tracheostomy, Pleural procedures